Nick Pizzie
Chief Financial Officer · 4 filings · Latest: Jun 9, 2026
Axsome Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
AXSM | Nick Pizzie | Chief Financial Officer | Jun 9, 2026 | Sale | $240.09 | 33,000 | $7.9M | 42,867 | |
AXSM | Nick Pizzie | Chief Financial Officer | Jun 9, 2026 | Option Exercise | $3.50 | 33,000 | $115.5K | 75,867 | |
AXSM | Pizzie Nick | — | Jun 9, 2026 | Proposed Sale | $240.09 | 33,000 | $7.9M | — | |
AXSM | Nick Pizzie | Chief Financial Officer | Jan 22, 2026 | Sale | $187.92 | 12,000 | $2.3M | 42,588 | |
AXSM | Nick Pizzie | Chief Financial Officer | Jan 22, 2026 | Option Exercise | $3.50 | 12,000 | $42.0K | 54,588 | |
AXSM | Pizzie Nick | — | Jan 22, 2026 | Proposed Sale | $187.92 | 12,000 | $2.3M | — | |
AXSM | Pizzie Nick | — | Feb 14, 2025 | Proposed Sale | $131.07 | 3,000 | $393.2K | — | |
AXSM | Pizzie Nick | — | Feb 13, 2025 | Proposed Sale | $129.86 | 12,000 | $1.6M | — |